For the first time in nearly three decades, researchers have discovered new antibiotics that could change how we treat dangerous bacterial infections. A team at Boston University identified 25 promising compounds using a revolutionary method — and the results, published in the journal Nature, are giving doctors and scientists real hope. For Canadians dealing with infections that no longer respond to standard treatments, this breakthrough could not have come at a better time.
Why New Antibiotics Matter Right Now
Antibiotics are among the most important medicines ever developed. They treat everything from ear infections and skin infections to life-threatening infections of the blood. Diseases that once wiped out entire populations are now manageable — largely because of antibiotics.
However, there is a growing problem. Bacteria are becoming resistant to the antibiotics we use most often. This means some infections are becoming very difficult — or even impossible — to treat. According to the World Health Organization (WHO), antimicrobial resistance is one of the biggest global health threats today.
In Canada, family doctors and specialists have been raising alarms about this trend for years. Infections that once cleared up in a week now sometimes require stronger medicines, longer hospital stays, or more complex care covered under provincial health plans.
No New Antibiotics for Almost 30 Years
The most productive era for antibiotic discovery was the 1950s and 1960s. Since 1987, researchers had not found a single new class of antibiotics worthy of clinical use. That is a gap of nearly four decades — and during that time, bacteria kept evolving.
As a result, several dangerous bacteria have developed resistance to many of our best treatments. Some of the most worrying examples include:
MRSA — a strain of Staphylococcus aureus (staph) resistant to many common antibiotics
Vancomycin-resistant Enterococcus (VRE) — a gut bacteria that no longer responds to a key antibiotic
Carbapenem-resistant E. coli and Enterobacter spp. — bacteria resistant to a powerful class of last-resort drugs
Carbapenem-resistant P. aeruginosa — a common hospital-acquired infection that is increasingly hard to treat
Cephalosporin-resistant K. pneumoniae — a bacteria that can cause severe lung and urinary infections
Furthermore, experts warn that bacterial resistance will continue to worsen over the next 20 years if new treatments are not found. That makes the recent discovery of new antibiotics especially significant.
How Researchers Discovered 25 New Antibiotics
The Boston University team took a completely different approach to finding new antibiotics. Instead of growing bacteria in a laboratory setting, they went back to nature — specifically, to soil.
Soil is home to billions of microorganisms. In fact, scientists estimate that only about 1% of soil bacteria can be grown artificially in a lab. The other 99% had never been properly studied — until now.
The Underground Hotel Method
The research team built what they described as an underground hotel for bacteria. This device allowed soil bacteria to grow in their natural environment while scientists studied them closely. By observing how these microbes behaved and what chemicals they produced, researchers could test those substances for antibiotic properties.
This method proved to be remarkably effective. It led to the discovery of 25 new antibiotic compounds — a major leap forward after decades of stagnation in antibiotic research.
Teixobactin: The Most Promising Discovery
Of the 25 new antibiotics identified, teixobactin stands out as the most exciting. In laboratory tests, it was effective against a wide range of dangerous infections, including:
Staphylococcus aureus (including MRSA)
Mycobacterium tuberculosis (the bacteria that causes tuberculosis)
Helicobacter pylori (H. pylori), which is linked to stomach ulcers
Teixobactin is so powerful that scientists believe it may even be able to destroy bacteria that have already developed resistance to other antibiotics. In laboratory tests, no significant side effects were observed. Researchers hope this new antibiotic could be available for clinical use within a few years.
However, it is important to note that teixobactin has not yet been tested in human trials. It also only works on gram-positive bacteria — meaning it cannot penetrate the outer protective layer of gram-negative bacteria like E. coli. Scientists acknowledge these limitations and are continuing their research. For more information on how antibiotics work, visit Mayo Clinic’s guide to antibiotics and resistance.
Understanding Antibiotic Resistance in Canada
Antibiotic resistance happens when bacteria change over time and stop responding to the medicines designed to kill them. This can happen naturally, but human behaviour speeds up the process significantly.
The most common causes of resistance include taking antibiotics when they are not needed, not finishing a full course of treatment, and using leftover antibiotics from a previous prescription. Each of these actions gives bacteria a chance to adapt and survive.
In Canada, Health Canada actively monitors antibiotic resistance and works with provinces to reduce unnecessary antibiotic use. Your provincial health plan supports access to proper diagnosis before any antibiotic is prescribed — and that step matters enormously.
What Patients Can Do
Every Canadian can play a role in slowing antibiotic resistance. Here are the steps that health experts recommend:
See your doctor first. Only a doctor can determine whether your infection is bacterial or viral. Antibiotics do not work on viruses — they will not help a cold or the flu.
Finish your full course. Even if you feel better after a few days, stopping early allows some bacteria to survive and become resistant.
Never use leftover antibiotics. Different antibiotics treat different types of infections. Using the wrong one can delay recovery and encourage resistant bacteria to grow.
Do not pressure your doctor for a prescription. If your doctor says you do not need antibiotics, trust that decision. It protects you and others.
Ask about your antibiogram. In some cases, your doctor may test which antibiotic works best against your specific bacteria before prescribing treatment.
What Healthcare Providers Can Do
Doctors, nurses, and pharmacists also have a responsibility to reduce antibiotic resistance. Best practices include prescribing antibiotics only after proper testing, choosing the right antibiotic at the right dose for the right duration, and staying alert to the spread of resistant bacteria within healthcare settings.
Hospitals and clinics across Canada follow strict infection control protocols to prevent resistant bacteria from spreading between patients. These efforts are part of a national strategy to preserve the effectiveness of the antibiotics we already have — while researchers work to develop new ones.
When to See a Doctor About an Infection
If you think you have a bacterial infection, do not wait and do not self-medicate. Contact your family doctor as your first step. If your family doctor is not available, a walk-in clinic can assess your symptoms and recommend the right course of action.
You should seek medical care promptly if you experience:
A fever that lasts more than two or three days
Symptoms that are getting worse instead of better
Signs of a skin infection, such as redness, warmth, or swelling that is spreading
Difficulty breathing, chest pain, or confusion — these require emergency care
A recurring infection that did not fully clear up after a previous course of antibiotics
Your doctor can determine whether you actually need antibiotics, which type is appropriate, and how long you should take them. This is always safer than guessing on your own. As with any health concern, it is best to speak with a qualified healthcare provider before starting or stopping any medication.
Frequently Asked Questions About New Antibiotics
What are the new antibiotics recently discovered by scientists?
Researchers at Boston University discovered 25 new antibiotics using a method that studies soil bacteria in their natural environment. The most promising of these new antibiotics is called teixobactin, which showed strong results against infections like MRSA and tuberculosis in laboratory tests. Human trials have not yet begun, but scientists are hopeful about its potential.
Why has antibiotic discovery been so slow for the past 30 years?
Most antibiotic research focused on growing bacteria in laboratory conditions, which only allows scientists to study about 1% of all known bacteria. This severely limited the discovery of new antibiotics for decades. The new soil-based method opens up the other 99% of bacteria for study, which is why researchers are so excited about its potential.
How does antibiotic resistance develop?
Antibiotic resistance develops when bacteria are exposed to antibiotics but not fully destroyed — for example, when a patient stops taking their medication early or takes the wrong antibiotic. The surviving bacteria adapt and pass on their resistance to future generations. Over time, this can make common infections much harder to treat, even with strong new antibiotics.
When will teixobactin be available as a treatment?
Teixobactin is still in the early stages of research and has not yet been tested in human clinical trials. Scientists are hopeful it could be ready for clinical use within several years, but drug development takes time and rigorous testing. Canadians should continue following their doctor’s advice regarding current antibiotic treatments in the meantime.
Can I get antibiotics at a walk-in clinic in Canada?
Yes, walk-in clinics in Canada can assess infections and prescribe antibiotics when appropriate. However, a doctor will first determine whether your infection is bacterial, since new antibiotics and existing ones are ineffective against viral infections. Your provincial health plan typically covers this type of visit, so there is no reason to self-medicate.
What happens if antibiotic resistance keeps getting worse?
If antibiotic resistance continues to grow, many common infections could become impossible to treat. Procedures like surgery, organ transplants, and chemotherapy all rely on effective antibiotics to prevent and treat infections — making resistance a serious threat to modern medicine. The discovery of new antibiotics is a critical step toward preventing this outcome.
Key Takeaways
25 new antibiotics have been discovered using an innovative soil-based research method developed at Boston University.
Teixobactin is the most promising of these new antibiotics, showing effectiveness against MRSA, tuberculosis, and other serious infections in lab tests.
No new antibiotic class had been approved for clinical use since 1987 — making this discovery a major turning point.
Antibiotic resistance is a growing threat in Canada and worldwide, driven largely by the misuse and overuse of existing antibiotics.
Every Canadian can help by only taking antibiotics when prescribed, finishing every course completely, and never using leftover medication.
See your family doctor or visit a walk-in clinic if you suspect a bacterial infection — do not self-diagnose or self-treat.
Always consult a healthcare provider before starting or stopping any antibiotic treatment.
